SAB Biotherapeutics raises $22M in series A-2 round

Immunotherapy company SAB Biotherapeutics Inc. (Sioux Falls, S.D.) raised $22 million in a series A-2 round. T. Denny Sanford, chairman and CEO of United National Corp. (Sioux Falls, S.D.), contribut...